Comparing DS Healthcare Group (DSKX) & Its Rivals

DS Healthcare Group (OTCMKTS: DSKX) is one of 32 public companies in the “Personal Products” industry, but how does it weigh in compared to its peers? We will compare DS Healthcare Group to similar companies based on the strength of its dividends, earnings, analyst recommendations, risk, profitability, institutional ownership and valuation.

Analyst Ratings

This is a summary of current recommendations for DS Healthcare Group and its peers, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DS Healthcare Group 0 0 0 0 N/A
DS Healthcare Group Competitors 360 1260 1523 24 2.38

As a group, “Personal Products” companies have a potential upside of 14.40%. Given DS Healthcare Group’s peers higher possible upside, analysts plainly believe DS Healthcare Group has less favorable growth aspects than its peers.

Profitability

This table compares DS Healthcare Group and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
DS Healthcare Group -62.31% -1,304.25% -117.85%
DS Healthcare Group Competitors -23.34% 73.78% 1.23%

Valuation and Earnings

This table compares DS Healthcare Group and its peers revenue, earnings per share (EPS) and valuation.

Gross Revenue NetIncome Price/Earnings Ratio
DS Healthcare Group $12.95 million -$6.93 million -0.11
DS Healthcare Group Competitors $16.34 billion $2.21 billion 407.02

DS Healthcare Group’s peers have higher revenue and earnings than DS Healthcare Group. DS Healthcare Group is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Risk & Volatility

DS Healthcare Group has a beta of 2.03, suggesting that its stock price is 103% more volatile than the S&P 500. Comparatively, DS Healthcare Group’s peers have a beta of 1.25, suggesting that their average stock price is 25% more volatile than the S&P 500.

Insider & Institutional Ownership

0.0% of DS Healthcare Group shares are owned by institutional investors. Comparatively, 57.1% of shares of all “Personal Products” companies are owned by institutional investors. 19.4% of DS Healthcare Group shares are owned by insiders. Comparatively, 15.3% of shares of all “Personal Products” companies are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

DS Healthcare Group peers beat DS Healthcare Group on 7 of the 9 factors compared.

DS Healthcare Group Company Profile

DS Healthcare Group, Inc., doing business as DS Laboratories, is a personal care, product development and marketing company. The Company develops and markets branded personal care products that address thinning hair conditions, skin care and other personal care needs. It develops technologies and products for hair care and personal care needs. Its technologies include Liposome Technology, which acts as a carrier agent, and is designed to enhance the act ion of the active ingredients in its products, and Nanosome Technology, which acts as a delivery vehicle, and is designed to infuse active compounds into targeted cells. The Company products are primarily sold under its DS Laboratories brand. It also sells certain products under its Polaris Labs and Sigma Skin brands. It markets and sells these products through salons, spas, department stores, specialty retailers and distributors. The Company offers products under three product categories: Hair Care, Skin Care and Personal Care.

Receive News & Ratings for DS Healthcare Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DS Healthcare Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply